Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial. [electronic resource]
Producer: 19980106Description: 21-8 p. digitalISSN:- 0003-4819
- 2-Aminopurine -- analogs & derivatives
- AIDS-Related Opportunistic Infections -- drug therapy
- Adult
- Aged
- Antibodies, Viral -- blood
- Antiviral Agents -- therapeutic use
- CD4 Lymphocyte Count
- Cross-Over Studies
- Double-Blind Method
- Famciclovir
- Female
- Herpes Simplex -- drug therapy
- Humans
- Male
- Middle Aged
- Proportional Hazards Models
- Regression Analysis
- Simplexvirus -- growth & development
- Virus Activation
- Virus Shedding
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.